Just one hour left in the shortened holiday trading session, so let Brad Smith and Josh Lipton lead you into the Christmas season by covering the biggest market stories heading into the closing bell.
BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins the program to discuss his latest price target cut on Novo Nordisk (NVO) and how the weight-loss drug innovator may fare against competitors in 2025.
Serpa Pinto Advisory Founder Jon Hilsenrath also weighs in on whether the Federal Reserve's latest interest rate cut last week was the right decision for the central bank in the long run.
To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
Other top trending stocks on the Yahoo Finance platform include American Airlines (AAL), Netflix (NFLX), and Vistra (VST).
This post was written by Luke Carberry Mogan.